More negative numbers indicated faster escape times and less learning impairment
GLP-1 medications are driving significant shifts in the pharmaceutical market, with soaring demand, rising prescriptions, and multi-billion-dollar growth projections
GLP-1 receptors show up not just in the pancreas but throughout the central and peripheral nervous systems, including the digestive tract's nerve network [1]
Body weight, insulin resistance severity, and metabolic goals also influence starting-dose selection
Neuron 93:12961313 Sun Y, Shu Y, Liu B, Liu P, Wu C, Zheng R, Zhang X, Zhuang Z, Deng Y, Zheng L, Xu Q, Jiang B, Ouyang X, Gao J, Xu N, Li X, Jiang S, Liang C, Yao Y (2016) A prospective study to evaluate the efficacy and safety of oral acetyl-l-carnitine for the treatment of chemotherapy-induced peripheral neuropathy